BioCentury
ARTICLE | Company News

Cornerstone BioPharma Inc., Critical Therapeutics deal

November 10, 2008 8:00 AM UTC

The companies completed their previously announced merger to form Cornerstone Therapeutics Inc. Cornerstone shareholders received 101.5 million Critical shares valued at $39.6 million based on Critic...